Yajing Wen

1.2k total citations · 1 hit paper
12 papers, 1.0k citations indexed

About

Yajing Wen is a scholar working on Pharmacology, Infectious Diseases and Neurology. According to data from OpenAlex, Yajing Wen has authored 12 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Pharmacology, 2 papers in Infectious Diseases and 2 papers in Neurology. Recurrent topics in Yajing Wen's work include Nanoplatforms for cancer theranostics (2 papers), NF-κB Signaling Pathways (2 papers) and Immune cells in cancer (2 papers). Yajing Wen is often cited by papers focused on Nanoplatforms for cancer theranostics (2 papers), NF-κB Signaling Pathways (2 papers) and Immune cells in cancer (2 papers). Yajing Wen collaborates with scholars based in China. Yajing Wen's co-authors include Lingjing Xue, Can Zhang, Jingwei Xue, Lingyi Kong, Ran Mo, Lei Zhang, Qineng Ping, Zekai Zhao, Lu Wang and Hongbin Sun and has published in prestigious journals such as Nature Nanotechnology, Small and Sustainability.

In The Last Decade

Yajing Wen

11 papers receiving 1.0k citations

Hit Papers

Neutrophil-mediated anticancer drug delivery for suppress... 2017 2026 2020 2023 2017 250 500 750

Peers

Yajing Wen
Yujie Su China
Zhao Hai China
Jie Zang China
Yonger Xue United States
Yajing Wen
Citations per year, relative to Yajing Wen Yajing Wen (= 1×) peers Kévin Vanvarenberg

Countries citing papers authored by Yajing Wen

Since Specialization
Citations

This map shows the geographic impact of Yajing Wen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yajing Wen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yajing Wen more than expected).

Fields of papers citing papers by Yajing Wen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yajing Wen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yajing Wen. The network helps show where Yajing Wen may publish in the future.

Co-authorship network of co-authors of Yajing Wen

This figure shows the co-authorship network connecting the top 25 collaborators of Yajing Wen. A scholar is included among the top collaborators of Yajing Wen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yajing Wen. Yajing Wen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Xu, Hongyan, et al.. (2024). Allergic disease and keratoconus: A two-sample univariable and multivariable Mendelian randomization study. World Allergy Organization Journal. 17(12). 100993–100993. 4 indexed citations
2.
Li, Yuanyuan, Yue Chen, Yuxin Li, et al.. (2024). Dickkopf-1 is an immune infiltration-related prognostic biomarker of head and neck squamous cell carcinoma. Aging. 16(4). 3837–3855. 1 indexed citations
4.
5.
Hu, Xingsheng, Chunhong Hu, Ping Zhong, Yajing Wen, & Xiangyu Chen. (2021). Risk factors associated with acute respiratory distress syndrome in COVID-19 patients outside Wuhan: A double-center retrospective cohort study of 197 cases in Hunan, China. World Journal of Clinical Cases. 9(2). 344–356. 4 indexed citations
6.
Song, Xiaopeng, Tianwen Ma, Yue Li, et al.. (2020). Aminoguanidine inhibits IL‑1β‑induced protein expression of iNOS and COX‑2 by blocking the NF‑κB signaling pathway in rat articular chondrocytes. Experimental and Therapeutic Medicine. 20(3). 2623–2630. 9 indexed citations
7.
Ma, Tianwen, Yajing Wen, Xiaopeng Song, et al.. (2020). Puerarin inhibits the development of osteoarthritis through antiinflammatory and antimatrix‐degrading pathways in osteoarthritis‐induced rat model. Phytotherapy Research. 35(5). 2579–2593. 24 indexed citations
8.
Hu, Xingsheng, Chunhong Hu, Yong Yang, et al.. (2020). Clinical characteristics and risk factors for severity of COVID-19 outside Wuhan: a double-center retrospective cohort study of 213 cases in Hunan, China. Therapeutic Advances in Respiratory Disease. 14. 3272698075–3272698075. 29 indexed citations
9.
Zhao, Jinghua, et al.. (2019). Effect of ketamine combined with DHA on lipopolysaccharide-induced depression-like behavior in rats. International Immunopharmacology. 75. 105788–105788. 25 indexed citations
10.
Ju, Caoyun, Yajing Wen, Luping Zhang, et al.. (2018). Neoadjuvant Chemotherapy Based on Abraxane/Human Neutrophils Cytopharmaceuticals with Radiotherapy for Gastric Cancer. Small. 15(5). e1804191–e1804191. 73 indexed citations
11.
Xue, Jingwei, Zekai Zhao, Lei Zhang, et al.. (2017). Neutrophil-mediated anticancer drug delivery for suppression of postoperative malignant glioma recurrence. Nature Nanotechnology. 12(7). 692–700. 813 indexed citations breakdown →
12.
Wen, Yajing, et al.. (2011). Immunological features in patients with pneumonitis due to influenza A H1N1 infection.. PubMed. 21(1). 44–50. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026